Thursday, January 31, 2013

Reuters: Health News: Celsion plunges 80 percent as liver cancer therapy fails trial

Celsion plunges 80 percent as liver cancer therapy fails trial

(Reuters) - Celsion Corp shares plunged by more than 80 percent after a late-stage study of the company's experimental liver cancer treatment ThermoDo...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/0H1RXeK84BQ/us-celsion-study-thermodox-idUSBRE90U0MI20130131


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Subscribe Now: Feed Icon

Subscribe in a reader